Previous 10 | Next 10 |
RADNOR, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and other neuropsychiatric...
Gainers: Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...
TRACON Pharmaceuticals (NASDAQ: TCON ) +25% on envafolimab deal . More news on: TRACON Pharmaceuticals, Inc., Care.com, Inc., Marinus Pharmaceuticals, Inc., Stocks on the move, Read more ...
Change Healthcare (NASDAQ: CHNG ) initiated with Outperform rating and $18 (23% upside) price target at Raymond James. More news on: Change Healthcare Inc., Health Catalyst, Inc., HealthStream, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
The following slide deck was published by Marinus Pharmaceuticals, Inc. in conjunction with this Read more ...
RADNOR, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the closing of an underwritten public offering of 32,200,000 shares of common stock at a public offering price of $1.25 per s...
Gainers: Camber Energy (NYSEMKT: CEI ) +130% . More news on: Camber Energy, Inc., Marinus Pharmaceuticals, Inc., Centogene N.V., Stocks on the move, Read more ...
3 Penny Stocks To Watch This Month Today’s likely to be tense day for blue-chip stocks . All eyes are focusing on the FOMC meetings that begin later today. So where can investors look for volatility? Penny stocks , of course. The cheap stocks have always been a “safe haven ...
RADNOR, Pa., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the pricing of an underwritten public offering of 28,000,000 shares of common stock at a public offering price of $1.25 per s...
Nano cap Marinus Pharmaceuticals ( MRNS +32.6% ) is up on triple normal volume on the heels of its public offering of 28M common shares at $1.25, apparently a more bullish price than investors were expecting (possibly aided by the convertible offering below). More news on: Marinus Phar...
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2024 on August 13, 2024. The Company will h...
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Lawsuit Filed by the Schall Law Firm PR Newswire LOS ANGELES , July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing ...
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the China National Medical Products Administration (NMPA) has approved ganaxolone oral suspension for the treatment of ...